AiVita Biomedical has launched a patented stem cell-derived formula that helps reduce the visible indications of skin aging under and around the eyes.
The product, dubbed Provoque Eye Complex, is said to be packaged in an easy-to-apply aesthetic cosmetic formulation.
The technology in the product is a stem cell-conditioned media featuring microelements, amino acids, vitamins, antioxidants, proteins, lipids, carbohydrates and factors secreted by skin progenitor cells
AiVita Biomedical research and development vice president Aleksandra Poole said: “We are excited to be making a new addition to our line of best-in-class stem cell-derived anti-aging products.
“Our unique capabilities in cell therapy development have allowed us to develop what we believe to be the most physiologically precise anti-aging product on the market, now in an eye complex formulation optimized to address the visible signs of aging around the eye.”
The new anti-aging skin care formula is specifically formulated to cover the functional concerns faced by eye aesthetics like thin periocular skin, dryness, under eye hyperpigmentation, fine line wrinkles and crow’s feet.
Provoque Eye Complex is the Californian stem cell company’s second product launch in its planned range of anti-aging skin care products following last year’s launch of Provoque Facial Serum.
The active technology behind the two anti-aging skin care products base is said to be supported by two clinical blinded trials which had established their performance and safety.